X-396

Generic Name: X-396

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₅H_₂₅Cl_₂FN_₆O_₃

CAS Number: 1365267-27-1

Unique Ingredient Identifier: 7DR7JMB8BH

Background: X-396 has been used in trials studying the treatment of Advanced Solid Tumors and Non-small Cell Lung Cancer.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Phase II Umbrella Study Directed by Next Generation Sequencing

Phase 2

Recruiting

Conditions: Carcinoma, Non-Small-Cell Lung

Interventions: Drug: Avitinib Maleate
Drug: Afatinib
Drug: Pyrotinib Maleate
Drug: Pirotinib
Drug: Nimotuzumab
Drug: Sintilimab
Drug: Crizotinib
Drug: X-396
Drug: AZD3759
Drug: Gemcitabine
Drug: Pemetrexed
Drug: Cisplatin
Drug: Chidamide
Drug: Carboplatin

First Posted Date: 2018-07-02

Last Posted Date: 2022-12-06

Lead Sponsor: Guangdong Association of Clinical Trials

Target Recruit Count: 400

Registration Number: NCT03574402

Locations: 🇨🇳
Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, Guangdong, China

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy